Evidence map›Paper›PMID 33624293›Full record

ArticleThe Journal of dermatology2021

Dermatological manifestations during COVID-19 and histological picture: Description of two clinical cases.

Paola Mencarini, Alessandra Scarabello, Franca Del Nonno, Eleonora Lalle, Laura Falasca, Gina Gualano, Roberta Nardacci, Silvia Mosti, Maria Musso, Raffaella Libertone and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of dermatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Paola MencariniRespiratory Infectious Diseases Unit, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, Rome, Italy.ORCID https://orcid.org/0000-0001-8928-8183
Alessandra ScarabelloDermatology Consultation Service, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, Rome, Italy.
Franca Del NonnoPathology Unit, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, Rome, Italy.
Eleonora LalleVirology Unit, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, Rome, Italy.
Laura FalascaLaboratory of Electron Microscopy, National Institute for Infectious Diseases "L. Spallanzani", IRCCS, Rome, Italy.
Gina GualanoRespiratory Infectious Diseases Unit, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, Rome, Italy.
Roberta NardacciLaboratory of Electron Microscopy, National Institute for Infectious Diseases "L. Spallanzani", IRCCS, Rome, Italy.
Silvia MostiRespiratory Infectious Diseases Unit, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, Rome, Italy.
Maria MussoRespiratory Infectious Diseases Unit, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, Rome, Italy.
Raffaella LibertoneRespiratory Infectious Diseases Unit, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, Rome, Italy.
Virginia Di BariRespiratory Infectious Diseases Unit, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, Rome, Italy.
Silvia RosatiRespiratory Infectious Diseases Unit, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, Rome, Italy.
Daniele ColomboPathology Unit, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, Rome, Italy.
Concetta CastillettiVirology Unit, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, Rome, Italy.
Fabrizio PalmieriRespiratory Infectious Diseases Unit, National Institute for Infectious Diseases "L. Spallanzani" IRCCS, Rome, Italy.
Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · IT

Funding

Italian Ministry of Health
6 · The paper itself

Abstract

It is not yet entirely clear what is the relevance of skin symptoms and what clinical implications are related to their appearance in COVID-19 patients. We describe two cases of COVID-19-associated pneumonia, which presented skin manifestations in advanced stage of illness, when nasopharyngeal swabs became negative for SARS-CoV-2. The first case presented erythematous, maculopapular lesions; the second developed petechial, vesicular and blood-encrusted lesions on the limbs. Histopathology documented perivascular lymphocytic infiltrates, with prevalent CD4+ T-cells in both patients. The research of SARS-CoV-2 in tissues with real time RT-PCR was negative. Basal keratinocytes displayed C4d deposits in one case, who developed laboratory signs indicative of a procoagulative condition at the same time as the skin rash. Skin manifestations during SARS-CoV-2 infection seem to be clinically relevant and further studies are necessary to assess if they are linked to systemic complications, lack of viral clearance or cascades of immune responses induced by the virus, even in patients affected by mild pneumonia.

Indexed as

COVID-19ExanthemaCOVID-19 TestingErythemaHumansSARS-CoV-2COVID-19inflammation markersrashSARS-CoV-2 infectionskin biopsy

Identifiers

PMID33624293
PMCPMC8013512
OpenAlexW3129396864

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.